Research and Markets: Atrial Fibrillation Pipeline Market 2014-2017
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mq83lp/atrial) has announced the addition of the "Atrial Fibrillation Pipeline Highlights - 2014 Update" report to their offering.
“Atrial Fibrillation Pipeline Highlights - 2014 Update”
The latest report Atrial Fibrillation Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Atrial Fibrillation market. It covers emerging therapies for Atrial Fibrillation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Key Topics Covered:
1. Atrial Fibrillation Pipeline by Stages
2. Atrial Fibrillation Pipeline by Drug Class
3. Atrial Fibrillation Pipeline by Company
4. Atrial Fibrillation Phase 3 Clinical Trial Insights
5. Atrial Fibrillation Phase 2 Clinical Trial Insights
6. Atrial Fibrillation Phase 1 Clinical Trial Insights
7. Atrial Fibrillation Preclinical Research Insights
8. Atrial Fibrillation Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/mq83lp/atrial